首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Glycosaminoglycans in infectious disease
Authors:Jonathan S Dordick  Robert J Linhardt
Institution:1. Department of Biology, Rensselaer Polytechnic Institute, , Troy, New York, 12180‐3590 U.S.A.;2. Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, , Troy, New York, 12180‐3590 U.S.A.;3. Department of Biomedical Engineering, Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute, , Troy, New York, 12180–3590, U.S.A.;4. Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, , Troy, New York, 12180‐3590 U.S.A.
Abstract:Glycosaminoglycans (GAGs) are complex carbohydrates that are ubiquitously present on the cell surface and in the extracellular matrix. Interactions between GAGs and pathogens represent the first line of contact between pathogen and host cell and are crucial to a pathogen's invasive potential. Their complexity and structural diversity allow GAGs to control a wide array of biological interactions influencing many physiological and pathological processes, including adhesion, cell‐to‐cell communication, biochemical cascades, and the immune response. In recent years, increasing evidence indicates an extraordinary role for GAGs in the pathogenesis of viruses, bacteria and parasites. Herein, we examine the interface between GAGs and different pathogens, and address the divergent biological functions of GAGs in infectious disease. We consider approaches to use this understanding to design novel therapeutic strategies addressing new challenges in the treatment of infectious diseases.
Keywords:glycosamimoglycans  infectious disease  virus  bacteria  parasites  protein‐carbohydrate interactions
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号